Officer rescues woman from burning car in aftermath of interstate crash in Phoenix

PHOENIX — A woman trapped inside a burning car on an interstate in west Phoenix was pulled to safety by an officer who happened to be driving by and busted through the glass on her window.
The rescue early Saturday morning unfolded as Officer Dakota Berry returned to his duties in nearby Goodyear after booking a suspect at a county jail. When he spotted the two-vehicle crash on Interstate 10, Berry could hear honking from the car that was in flames and realized someone was inside.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Washington Post

20 minutes ago

• Washington Post

Trump calls for special prosecutor to investigate 2020 election, reviving longstanding grievance

WASHINGTON — President Donald Trump on Friday called for the appointment of a special prosecutor to investigate the 2020 election won by Democrat Joe Biden, repeating his baseless claim that the contest was marred by widespread fraud. 'Biden was grossly incompetent, and the 2020 election was a total FRAUD!' Trump said in a social media post in which he also sought to favorably contrast his immigration enforcement approach with that of the former president. 'The evidence is MASSIVE and OVERWHELMING. A Special Prosecutor must be appointed. This cannot be allowed to happen again in the United States of America! Let the work begin!'

Medscape

20 minutes ago

• Medscape

Key Abstracts in Early-Stage NSCLC From ASCO 2025

Dr Jonathan Goldman of the University of California, Los Angeles, highlights key abstracts in early-stage NSCLC from ASCO 2025. Dr Goldman begins with updated results from CheckMate 816, comparing neoadjuvant chemotherapy (chemo) vs chemo + nivolumab. Median overall survival (OS) in the nivolumab arm remains unreached vs 73.7 months with chemo alone. Event-free survival (EFS) is durable at 59.6 vs 21.1 months, as evidenced by 5-year EFS of 49% in the combination arm. Next, he reviews the NeoADAURA trial evaluating neoadjuvant osimertinib ± chemo in resectable EGFR-mutated stage II-IIIB NSCLC. Major pathologic response was higher in osimertinib-containing arms (26% and 25%) vs 2% in the chemo arm, although long-term outcomes remain pending. Dr Goldman also discusses the SWOG/NRG S1914 trial of perioperative stereotactic body radiotherapy ± atezolizumab, which did not show improvements in OS or progression-free survival (PFS). He then highlights a prospective, low-dose CT screening study of the Mississippi Delta cohort, which showed a 4.7% lung cancer detection rate overall and 4.5% in patients with incidental pulmonary nodules — underscoring the utility of low-dose CT as a modality in early detection. In closing, he reports on two studies in small cell lung cancer. The IMforte study showed that lurbinectedin + atezolizumab in 1L maintenance improved PFS (HR, 0.54). In the DeLLphi-304 study, second-line tarlatamab improved OS compared to chemo (HR, 0.6), which is a potentially practice-changing update.

Wall Street Journal

25 minutes ago

• Wall Street Journal

Health Insurers to Promise Changes to Preapproval Process That Drew Backlash

Following the backlash that hit health insurers after the killing of a top executive last year, the industry will pledge steps meant to smooth the controversial preapproval process that can deny or delay access to care. The initiative is set to be unveiled early next week, according to people familiar with the matter.